Medigene, Inc. is a biotechnology company based in San Diego, California, specializing in the development of innovative immunotherapies for cancer treatment. The company focuses on harnessing the power of the immune system to create personalized therapies that target specific cancer antigens. Medigene's research encompasses T-cell therapy and dendritic cell vaccines, aiming to enhance the efficacy of cancer treatments while minimizing side effects. Through its advanced technologies, Medigene is committed to improving patient outcomes in oncology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

10 Patents

#534 in San Diego, CA

#7,118 in California

#29,882 in US

#56,092 in the World

San Diego, CA, United States of America

Medigene, Inc.

Forward Citations = 127

16 inventors:

Ian Richard Matthews (3 out of 9 patents)

Bent Karsten Jakobsen (2 out of 32 patents)

Meir Glick (2 out of 5 patents)

4. Dong Qiang (2 out of 2 patents)

5. Brian Horsburgh (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Medigene, Inc.. Retrieved from https://idiyas.com/company/medigene

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]